Clincosm LogoSign in Get a demo

congenital heart diseases

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Congenital Heart Diseases Trial in Montpellier (Therapeutic education, Standard follow-up)

Completed
  • Congenital Heart Diseases
  • Therapeutic education
  • Standard follow-up
  • Montpellier, France
    Pediatric and Congenital Cardiology and Pulmonology Department,
Dec 13, 2022

Physical Activity and Cognitive Development in Children

Recruiting
  • Congenital Heart Diseases
  • Children
  • structured physical activity program
  • New York, New York
    Columbia University Irving Medical Center / NewYork-Presbyterian
Oct 17, 2022

Congenital Heart Diseases, Hemodynamic, Cardiac Output Trial in Clermont-Ferrand (Innocor®, Physioflow®)

Unknown status
  • Congenital Heart Diseases
  • +2 more
  • Innocor®
  • Physioflow®
  • Clermont-Ferrand, France
    CHU Clermont-Ferrand
Feb 1, 2019

Congenital Heart Diseases, Aortic Valve Disorder Trial in Palo Alto (Cefazolin 25 mg/kg body weight and Vancomycin HCl,

Completed
Has Results
  • Congenital Heart Diseases
  • Aortic Valve Disorder
  • Cefazolin 25 mg/kg body weight and Vancomycin hydrochloride
  • Cefazolin 30 mg/kg body weight
  • Palo Alto, California
    Lucile Packard Children's Hospital at Stanford
Apr 16, 2018

Congenital Heart Diseases Trial in Guangzhou, Nanjing, Shanghai (Ulinastatin)

Unknown status
  • Congenital Heart Diseases
  • Guangzhou, Guangdong, China
  • +4 more
Jan 16, 2018

"Incidence and Consequences of Disorders of Glycosylation in

Unknown status
  • Congenital Heart Diseases
  • +3 more
  • none intervention
  • Barcelona, Spain
    Vall d'Hebron Hospital
Mar 24, 2017

Congenital Heart Diseases Trial in Xi'an (Sevoflurane, Control)

Unknown status
  • Congenital Heart Diseases
  • Xi'an, Shaanxi, China
    Department of Cardiovascular Surgery, Xijing Hospital
Nov 24, 2011